Meeting
2016 Palliative and Supportive Care in Oncology Symposium
OAMs at the end: The end of the beginning or the beginning of the end?
Authors
Annemarie P Hargadon
UC Davis Medical Center, Sacramento, CA
Annemarie P Hargadon, Barbara Marie Galligan, Chintan Shah, Iris Chen Zhao, Brian Paciotti, Nathan Fairman, Quy Tran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Biologic Basis of Symptoms and Treatment Toxicities,Psycho-oncology,End-of-Life Care,Survivorship,Management/Prevention of Symptoms and Treatment Toxicities,Psychosocial and Spiritual Care,Communication in Advanced Cancer
Sub Track
Treatment toxicity
Citation
J Clin Oncol 34, 2016 (suppl 26S; abstr 229)
DOI
10.1200/jco.2016.34.26_suppl.229
Abstract #
229
Poster Bd #
J5
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Proposition of a drug score to predict the clinical usefulness of therapeutic dose monitoring of oral molecularly targeted therapies.
First Author: Arthur Geraud
Poster
2018 ASCO Annual Meeting
Duration of physician-industry relationships and prescribing changes in oncology.
First Author: Aaron Philip Mitchell
Poster
2018 ASCO Annual Meeting
A retrospective natural history study of patients (pts) with PDGFRα D842V mutant advanced gastrointestinal stromal tumor (GIST) previously treated with a tyrosine kinase inhibitor (TKI).
First Author: Margaret von Mehren
Poster
2016 ASCO Annual Meeting
Frequency and risk factors for tyrosine kinase inhibitor–associated cardiotoxicity.
First Author: Peter J. Hurley